MedPath

Investigation of the Effectiveness of Schema Therapy and Cognitive-Behavioral Therapy in Patients with Major Depressive Disorder

Phase 3
Conditions
Major Depressive Disorder.
Major depressive disorder, recurrent, moderate
F33.1
Registration Number
IRCT20220504054739N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
45
Inclusion Criteria

A BDI greater score than or equal to 20
Fulfilling all diagnostic criteria of major depressive disorder based on the SCID-5
Providing written informed consent for participation in the study by participants
No presence of any other mental disorders
No history of mental illness
No dependence on alcohol or drugs
Do not receive other current psychological treatment

Exclusion Criteria

Presence of any suicide thoughts and beliefs
More than two absences in treatment sessions

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath